Compounds > phosphatidylcholines
Page last updated: 2024-09-05

phosphatidylcholines and ceritinib

phosphatidylcholines has been researched along with ceritinib in 1 studies

Compound Research Comparison

Studies
(phosphatidylcholines)		Trials
(phosphatidylcholines)		Recent Studies (post-2010)
(phosphatidylcholines)		Studies
(ceritinib)		Trials
(ceritinib)		Recent Studies (post-2010) (ceritinib)
32,2044435,59332935322

Protein Interaction Comparison

ProteinTaxonomyphosphatidylcholines (IC50)ceritinib (IC50)
Tyrosine-protein kinase JAK2Homo sapiens (human)1.385
Rho-associated protein kinase 2Homo sapiens (human)1.27
Serine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)3.7
Tyrosine-protein kinase ABL1Homo sapiens (human)1.25
Epidermal growth factor receptorHomo sapiens (human)0.7757
High affinity nerve growth factor receptorHomo sapiens (human)2.727
Insulin receptorHomo sapiens (human)0.1525
Tyrosine-protein kinase LckHomo sapiens (human)0.616
NucleophosminHomo sapiens (human)0.026
Tyrosine-protein kinase LynHomo sapiens (human)1.573
Proto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)1.352
Insulin-like growth factor 1 receptorHomo sapiens (human)0.209
Hepatocyte growth factor receptorHomo sapiens (human)1.5933
Cytochrome P450 3A4Homo sapiens (human)3.36
Proto-oncogene tyrosine-protein kinase ROSHomo sapiens (human)0.2697
Tyrosine-protein kinase FgrHomo sapiens (human)1.947
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 22.86
Mast/stem cell growth factor receptor KitHomo sapiens (human)2.0675
Cyclin-dependent kinase 4Homo sapiens (human)4.72
Proto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)1.694
Platelet-derived growth factor receptor alphaHomo sapiens (human)1.14
Fibroblast growth factor receptor 2Homo sapiens (human)0.26
Fibroblast growth factor receptor 4Homo sapiens (human)0.95
Fibroblast growth factor receptor 3Homo sapiens (human)0.43
Tyrosine-protein kinase JAK1Homo sapiens (human)3.73
Cyclin-dependent kinase 2Homo sapiens (human)3.97
Vascular endothelial growth factor receptor 2Homo sapiens (human)4.21
Receptor-type tyrosine-protein kinase FLT3Homo sapiens (human)1.0965
Transcription factor ETV6Homo sapiens (human)3.25
Tyrosine-protein kinase ZAP-70Homo sapiens (human)9.7
Tyrosine-protein kinase SYKHomo sapiens (human)3.05
Tyrosine-protein kinase JAK3Homo sapiens (human)7.92
Tyrosine-protein kinase BTKHomo sapiens (human)3.36
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)1.25
BDNF/NT-3 growth factors receptorHomo sapiens (human)1.829
Testis-specific serine/threonine-protein kinase 1Homo sapiens (human)0.023
MAP kinase-interacting serine/threonine-protein kinase 2Homo sapiens (human)2.24
Echinoderm microtubule-associated protein-like 4Homo sapiens (human)0.5935
ALK tyrosine kinase receptorHomo sapiens (human)0.1102

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bashawat, M; Fischer, M; Luck, M; Ludwig, K; Müller, P; Scheidt, HA; Vogel, A; Werle, M1

Other Studies

1 other study(ies) available for phosphatidylcholines and ceritinib

ArticleYear
The small-molecule kinase inhibitor ceritinib, unlike imatinib, causes a significant disturbance of lipid membrane integrity: A combined experimental and MD study.
    Chemistry and physics of lipids, 2023, Volume: 257

    Topics: Cholesterol; Imatinib Mesylate; Lipid Bilayers; Phosphatidylcholines; Protein Kinase Inhibitors

2023